Work

EE666 Cost-Effectiveness of Duvelisib Versus the Bendamustine Plus Rituximab Regimen for Relapsed/Refractory Follicular Lymphoma Patients in China

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.09.931

Authors: L. Chen, B. Tan, X. Gao, K. Zhou, J. Zhao, J. Xuan

Institutions: Sun Yat-sen University, Shanghai Centennial Scientific (China)

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4390125870

Cites:

Cited by: 2

Related to: 10